EcoDrugPlus

Matrix Metallopeptidase 2

Ensembl ID : ENSECRG00000014263
Gene Symbol: MMP2
3 Cross references
210 Possible Orthologues:

Matrix Metalloproteinase-20-Like

Ensembl ID : ENSECRG00000005212
Gene Symbol: LOC114650505
2 Cross references
165 Possible Orthologues:

Matrix Metalloproteinase-9-Like

Ensembl ID : ENSECRG00000008819
Gene Symbol: LOC114659397
3 Cross references
217 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSECRG00000019706
Gene Symbol: MTOR
3 Cross references
224 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSECRG00000017598
Gene Symbol: MC1R
3 Cross references
159 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSECRG00000011450
Gene Symbol: MC3R
1 Cross references
139 Possible Orthologues:

Melanocortin Receptor 4-Like

Ensembl ID : ENSECRG00000005098
Gene Symbol: LOC114653477
3 Cross references
229 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSECRG00000001918
Gene Symbol: MTNR1A
3 Cross references
216 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSECRG00000007142
Gene Symbol: MME
3 Cross references
236 Possible Orthologues:

Metabotropic Glutamate Receptor 3-Like

Ensembl ID : ENSECRG00000016569
Gene Symbol: LOC114668883
3 Cross references
281 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSECRG00000006884
Gene Symbol: METAP2
3 Cross references
230 Possible Orthologues:

Microtubule Associated Protein Tau

Ensembl ID : ENSECRG00000018220
Gene Symbol: MAPT
2 Cross references
227 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).